Your browser doesn't support javascript.
loading
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
Pal, Sumanta K; Rosenberg, Jonathan E; Hoffman-Censits, Jean H; Berger, Raanan; Quinn, David I; Galsky, Matthew D; Wolf, Juergen; Dittrich, Christian; Keam, Bhumsuk; Delord, Jean-Pierre; Schellens, Jan H M; Gravis, Gwenaelle; Medioni, Jacques; Maroto, Pablo; Sriuranpong, Virote; Charoentum, Chaiyut; Burris, Howard A; Grünwald, Viktor; Petrylak, Daniel; Vaishampayan, Ulka; Gez, Eliahu; De Giorgi, Ugo; Lee, Jae-Lyun; Voortman, Jens; Gupta, Sumati; Sharma, Sunil; Mortazavi, Amir; Vaughn, David J; Isaacs, Randi; Parker, Katie; Chen, Xueying; Yu, Kun; Porter, Dale; Graus Porta, Diana; Bajorin, Dean F.
Afiliación
  • Pal SK; City of Hope, Duarte, California.
  • Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hoffman-Censits JH; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Berger R; The Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Quinn DI; USC Norris Cancer Center, Los Angeles, California.
  • Galsky MD; The Mount Sinai Hospital, New York, New York.
  • Wolf J; Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
  • Dittrich C; Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna), Kaiser-Franz-Josef-Spital, Vienna, Austria.
  • Keam B; Seoul National University Hospital, Seoul, South Korea.
  • Delord JP; IUCT Oncopole, Toulouse, France.
  • Schellens JHM; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Gravis G; Institut Paoli Calmettes, Marseilles, France.
  • Medioni J; Hôpital Européen Georges Pompidou, Paris, France.
  • Maroto P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Sriuranpong V; Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Charoentum C; Maharaj Nakorn Chiangmai Hospital, Chiang Mai, Thailand.
  • Burris HA; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Grünwald V; Medical School Hannover, Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany.
  • Petrylak D; Yale School of Medicine, New Haven, Connecticut.
  • Vaishampayan U; Wayne State University/Karmanos Cancer Institute, Detroit, Michigan.
  • Gez E; Tel-Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel.
  • De Giorgi U; Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Voortman J; VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Gupta S; Huntsman Cancer Institute (University of Utah), Salt Lake City, Utah.
  • Sharma S; Huntsman Cancer Institute (University of Utah), Salt Lake City, Utah.
  • Mortazavi A; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Vaughn DJ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Isaacs R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Parker K; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Chen X; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Yu K; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Porter D; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Graus Porta D; Novartis Pharma AG, Basel, Switzerland.
  • Bajorin DF; Memorial Sloan Kettering Cancer Center, New York, New York. bajorind@mskcc.org.
Cancer Discov ; 8(7): 812-821, 2018 07.
Article en En | MEDLINE | ID: mdl-29848605
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Pirimidinas / Neoplasias Urológicas / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Mutación Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Pirimidinas / Neoplasias Urológicas / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Mutación Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2018 Tipo del documento: Article